Opportunity Information: Apply for PAR 18 225

The NIDA Core "Center of Excellence" Grant Program uses the NIH P30 center mechanism to support a coordinated, core-based research hub focused on drug abuse and addiction. The central idea is to bring together investigators who already hold active research support (from NIH and/or other federal, state, local, philanthropic, or other non-federal sources) and make their collective work stronger and more impactful through shared infrastructure, coordinated scientific direction, and intentional integration across projects. Rather than funding a collection of loosely related studies, the program is designed to create a true center with an organizing scientific theme and shared resources that allow investigators to do work they could not do as effectively on their own.

A key expectation is that the Center meaningfully transforms knowledge in its scientific area. The opportunity is explicitly not aimed at incremental progress or routine extensions of ongoing work. Instead, NIDA is signaling that it wants applications that leverage existing funded projects as a platform for new, creative directions in drug abuse and addiction research. In practice, that means the proposed cores and center activities should be designed to accelerate innovation, enable cross-project collaboration, and open up new lines of inquiry or new capabilities (for example, shared methods, harmonized datasets, advanced analytics, specialized clinical/research infrastructure, dissemination resources, or other center-wide assets). Each core is expected to clearly connect back to the center's integrating theme and to demonstrably improve the productivity, quality, or reach of the affiliated research projects.

The program also emphasizes community-building and field-building. Centers are expected to provide research opportunities and experiences for new investigators, which commonly includes structured mentoring, pilot opportunities, access to shared tools and expertise, and pathways for early-career researchers to plug into the center's ecosystem. Another major expectation is responsible sharing of findings, data, and resources. NIDA is looking for centers that do not operate as closed silos, but instead contribute to broader progress by making outputs available in ways that are consistent with program goals and NIH policies.

This is a discretionary grant opportunity administered by the National Institutes of Health, specifically NIDA, and it is identified under Funding Opportunity Number PAR 18 225 and CFDA 93.279. The activity area is categorized under Education and Health, and the funding instrument is a grant using the P30 core center model. The title notes "Clinical Trial Optional," which indicates that the program can accommodate applications that include clinical trial activity when appropriate, but it is not inherently limited to clinical trials; applicants can propose a center that is clinical-trial focused, trial-enabled, or not trial-based depending on the scientific plan and NIDA requirements for the specific application.

Eligibility is broad and includes many types of U.S.-based organizations and governments. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations both with and without 501(c)(3) status (excluding institutions of higher education where applicable); for-profit organizations (other than small businesses) and small businesses; and other eligible entities. The opportunity also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments other than federally recognized, and U.S. territories or possessions.

At the same time, the opportunity draws a firm boundary around foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply. Non-domestic components of U.S. organizations are not eligible to apply. In addition, foreign components, as NIH defines them in the NIH Grants Policy Statement, are not allowed. These restrictions mean the applicant organization and the proposed center activities must be structured so that the work and the organizational components funded under the award remain domestic under NIH rules.

The opportunity record lists an original closing date of 2020-01-07 and a creation date of 2017-11-30, and it does not specify an award ceiling or expected number of awards in the provided source text. Overall, the program is best understood as NIDA support for a high-impact, theme-driven research center that uses shared cores to integrate and amplify existing funded projects, deliberately pushes into innovative directions in addiction science, trains and supports new investigators, and shares outputs and resources to advance the field.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2017-11-30.
  • Applicants must submit their applications by 2020-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 18 225

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs): NIDA Core "Center of Excellence" Grant Program (P30)

What is the NIDA Core "Center of Excellence" Grant Program?

It is a discretionary NIH/NIDA grant program that uses the NIH P30 core center mechanism to support a coordinated, core-based research hub focused on drug abuse and addiction. The goal is to create a true center (not a loose collection of projects) with an organizing scientific theme and shared resources that strengthen and integrate the work of affiliated investigators.

What is the main purpose of using a P30 core center model for this opportunity?

The P30 model is used to build shared infrastructure and coordinated scientific direction through cores that serve multiple projects. The center is expected to amplify the impact of investigators who already have active research support by providing shared capabilities and intentional integration across projects.

What makes this program different from funding multiple independent studies?

This program is designed to build an integrated center with a unifying theme and shared resources that enable work investigators could not do as effectively on their own. It is not intended to support a set of loosely related studies operating independently.

What scientific areas does the program focus on?

The program focuses on drug abuse and addiction research. The center should have an integrating scientific theme within that area and demonstrate how cores and center activities advance that theme.

Does the program support incremental or routine extensions of ongoing work?

No. A key expectation is that the center meaningfully transforms knowledge in its scientific area. The opportunity is explicitly not aimed at incremental progress or routine extensions of existing work.

What does NIDA mean by a center that "meaningfully transforms knowledge"?

Based on the description provided, NIDA is looking for centers that use existing funded projects as a platform for new, creative directions in addiction research. Proposed cores and center activities should accelerate innovation, drive cross-project collaboration, and open new lines of inquiry or capabilities.

Who are the investigators expected to participate in the center?

The center is intended to bring together investigators who already hold active research support (from NIH and/or other federal, state, local, philanthropic, or other non-federal sources) and enhance the collective impact of their work through shared infrastructure and integration.

What are "cores" in this program?

Cores are shared resources and services that support multiple affiliated projects and investigators. Each core is expected to connect clearly back to the center's integrating theme and improve the productivity, quality, or reach of the affiliated research projects.

What kinds of shared resources or center-wide assets might a core provide?

Examples mentioned include shared methods, harmonized datasets, advanced analytics, specialized clinical/research infrastructure, dissemination resources, and other center-wide assets designed to enable cross-project collaboration and innovation.

How should cores relate to the center's theme?

Each core should be explicitly tied to the center's integrating scientific theme and should demonstrate how it strengthens affiliated projects and helps the center achieve coordinated, high-impact outcomes.

What is expected regarding collaboration across projects?

Integration is a central expectation. The center should be organized to promote cross-project collaboration and coordinated scientific direction, rather than operating as independent projects under one umbrella.

What does the program expect in terms of innovation?

The center activities and cores should be designed to accelerate innovation and enable new capabilities and directions in addiction science that would be difficult to achieve without shared infrastructure and coordinated planning.

Does the program require clinical trials?

No. The opportunity title notes "Clinical Trial Optional," meaning applications may include clinical trial activity when appropriate, but a center does not need to be trial-based. Applicants can propose a clinical-trial focused, trial-enabled, or non-trial center depending on the scientific plan and NIDA requirements for the application.

What is the Funding Opportunity Number (FON) for this program?

The Funding Opportunity Number is PAR 18 225.

What is the CFDA number associated with this opportunity?

The CFDA number listed is 93.279.

Which federal agency administers this grant opportunity?

It is administered by the National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA).

What is the funding instrument and mechanism?

The funding instrument is a grant, and the mechanism is the NIH P30 core center model.

How is the activity area categorized in the opportunity record?

The activity area is categorized under Education and Health.

Who is eligible to apply?

Eligibility is broad and includes many U.S.-based organizations and governments. Eligible applicants include state, county, city/township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations (with or without 501(c)(3) status, excluding institutions of higher education where applicable); for-profit organizations (other than small businesses) and small businesses; and other eligible entities.

Are minority-serving institutions and community-based organizations eligible?

Yes. The opportunity highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISI institutions, Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, and regional organizations (among others listed).

Are U.S. territories or possessions eligible to apply?

Yes. U.S. territories or possessions are listed among additional eligible applicants.

Are foreign (non-U.S.) organizations eligible to apply?

No. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply.

Can a U.S. organization apply if it has a non-domestic component?

Non-domestic components of U.S. organizations are not eligible to apply under this opportunity, based on the restrictions stated.

Are foreign components allowed in the proposed work?

No. Foreign components (as NIH defines them in the NIH Grants Policy Statement) are not allowed. The applicant organization and proposed center activities must be structured so that the work and organizational components funded under the award remain domestic under NIH rules.

What does the opportunity emphasize about sharing data and resources?

The program emphasizes responsible sharing of findings, data, and resources. NIDA is looking for centers that do not operate as closed silos and that make outputs available in ways consistent with program goals and NIH policies.

What does the opportunity say about developing new investigators?

Community-building and field-building are emphasized. Centers are expected to provide research opportunities and experiences for new investigators, commonly including structured mentoring, pilot opportunities, access to shared tools and expertise, and pathways for early-career researchers to engage with the center.

Is there an expectation that the center supports early-career researchers?

Yes. The opportunity explicitly highlights providing opportunities and experiences for new investigators, including mentoring and ways to plug into the center's ecosystem.

Is this opportunity intended to fund entirely new standalone research projects?

The central idea is to bring together investigators with active research support and strengthen their collective work through shared cores and coordination. The center leverages existing funded projects as a platform for new, creative directions rather than functioning as a set of standalone, unrelated projects.

What does the opportunity record say about the closing date?

The opportunity record lists an original closing date of 2020-01-07.

What does the opportunity record say about when it was created?

The opportunity record lists a creation date of 2017-11-30.

Does the provided information include an award ceiling or the expected number of awards?

No. The provided source text does not specify an award ceiling or the expected number of awards.

How should an applicant think about the overall goal of this program?

The program supports a high-impact, theme-driven addiction research center that uses shared cores to integrate and amplify existing funded projects, pushes into innovative directions, trains and supports new investigators, and shares outputs and resources to advance the field.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Cutting-Edge Basic Research Awards (CEBRA) (R21-Clinical Trial Optional)

Previous opportunity: Research Needs Related to Developing Technologies for Advancement of Geologic Storage in Basinal Geo-laboratories

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 18 225

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 18 225) also looked into and applied for these:

Funding Opportunity
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Apply for PAR 18 292

Funding Number: PAR 18 292
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Pilot and Feasibility Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional) Apply for PAR 18 223

Funding Number: PAR 18 223
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $225,000
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21 Clinical Trial Optional) Apply for PAR 18 250

Funding Number: PAR 18 250
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01 Clinical Trial Optional) Apply for PAR 18 251

Funding Number: PAR 18 251
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Apply for PAR 18 222

Funding Number: PAR 18 222
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional) Apply for PAR 18 226

Funding Number: PAR 18 226
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Obesity and Asthma: Awareness and Self- Management (R01 Clinical Trial Optional) Apply for PA 18 379

Funding Number: PA 18 379
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Apply for PAR 18 476

Funding Number: PAR 18 476
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
Cancer Research Education Grants Program - Research Experiences (R25) Apply for PAR 18 478

Funding Number: PAR 18 478
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Cancer Research Education Grants Program - Courses for Skills Development (R25) Apply for PAR 18 477

Funding Number: PAR 18 477
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
NIDA Avant-Garde Award Program for HIV/AIDS and Drug Use Research (DP1, Clinical Trial Optional) Apply for RFA DA 18 019

Funding Number: RFA DA 18 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Apply for PAR 18 467

Funding Number: PAR 18 467
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Apply for PAR 18 466

Funding Number: PAR 18 466
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Apply for PA 18 492

Funding Number: PA 18 492
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Apply for PA 18 493

Funding Number: PA 18 493
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trials Optional) Apply for RFA DA 19 002

Funding Number: RFA DA 19 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $3,000,000
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R01 Clinical Trial Optional) Apply for PA 18 498

Funding Number: PA 18 498
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Device-Based Treatments for Substance Use Disorders (UG3/UH3) (Clinical Trial Optional) Apply for PAR 18 494

Funding Number: PAR 18 494
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
End-of-Life and Palliative Care Health Literacy: Improving Outcomes in Serious, Advanced Illness (R21 Clinical Trial Optional) Apply for PA 18 499

Funding Number: PA 18 499
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) Apply for PA 18 503

Funding Number: PA 18 503
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 18 225", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: